Comparison of clinical efficacy and safety between indacaterol and tiotropium in COPD: meta-analysis of randomized controlled trials.

Comparison of clinical efficacy and safety between indacaterol and tiotropium in COPD: meta-analysis of randomized controlled trials.

Two once-daily inhaled bronchodilators, indacaterol and tiotropium, are widely used as first-line therapy in stable COPD patients. This study was performed to compare the clinical efficacy and safety between indacaterol and tiotropium in patients with moderate-to-severe COPD. MEDLINE, EMBASE, and Co...

Full description

Bibliographic Details
Main Authors:	Jung Soo Kim, Jinkyeong Park, Seong Yong Lim, Yeon-Mok Oh, Kwang Ha Yoo, Yong Bum Park, Seung Soo Sheen, Min-Ji Kim, K C Carriere, Ji Ye Jung, Hye Yun Park
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2015-01-01
Series:	PLoS ONE
Online Access:	http://europepmc.org/articles/PMC4370711?pdf=render

Similar Items

Effects of indacaterol versus tiotropium on exercise tolerance in patients with moderate COPD: a pilot randomized crossover study
by: Danilo Cortozi Berton, et al.

Effects of combination therapy indacaterol/glycopyrronium versus tiotropium on moderate to severe COPD: evaluation of impulse oscillometry and exacerbation rate
by: Antonio Molino, et al.
Published: (2017-09-01)

Tiotropium - Advancing the treatment of COPD
by: Chambers, S, et al.
Published: (2008)

Escalation Time to Open Triple Combination Therapy from the Initiation of LAMA versus ICS/LABA in COPD Management: Findings from Comparing the Incidence of Tiotropium and ICS/LABA in Real-World Use in South Korea (CITRUS) Study
by: Ye Jin Lee, et al.
Published: (2021-12-01)

High urinary desmosine is associated with long-term mortality in patients with COPD
by: Changhwan Kim, et al.
Published: (2023-06-01)

Cost-Effectiveness Analysis of Fixed-Dose Tiotropium/Olodaterol versus Tiotropium for COPD Patients in China
by: Lan Y, et al.
Published: (2023-09-01)

Preparation and Evaluation of Mucus-Penetrating Inhalable Microparticles of Tiotropium Bromide Containing Sodium Glycocholate
by: Yong-Bin Kwon, et al.
Published: (2022-07-01)

Cost-utility analysis of indacaterol in Germany: a once-daily maintenance bronchodilator for patients with COPD.
by: Price, D, et al.
Published: (2011)

Sarcopenia is associated with cardiovascular risk in men with COPD, independent of adiposity
by: Ah Young Leem, et al.
Published: (2022-07-01)

FVC, but not FEV1, is associated with clinical outcomes of asthma-COPD overlap
by: Tai Joon An, et al.
Published: (2022-08-01)

COST-EFFECTIVENESS OF VILANEROL / UMECLIDINIUM VERSUS TIOTROPIUM IN SEVERE AND VERY SEVERE COPD
by: E. G. Kosolapov, et al.
Published: (2017-08-01)

Mometasone/Indacaterol/Glycopyrronium (MF/IND/GLY) and MF/IND at Different MF Strengths versus Fluticasone Propionate/Salmeterol Xinafoate (FLU/SAL) and FLU/SAL+ Tiotropium in Patients with Asthma
by: van Zyl-Smit RN, et al.
Published: (2023-01-01)

Effect of Broncho-Vaxom (OM-85) on the frequency of chronic obstructive pulmonary disease (COPD) exacerbations
by: Joon Young Choi, et al.
Published: (2023-10-01)

The cost-effectiveness of tiotropium for the treatment of chronic obstructive pulmonary disease (COPD): the importance of the comparator.
by: Neyt, M, et al.
Published: (2012)

The cost-effectiveness of tiotropium for the treatment of chronic obstructive pulmonary disease (COPD): the importance of the comparator
by: Neyt, M, et al.
Published: (2012)

Effect of tiotropium on health-related quality of life as a primary efficacy endpoint in COPD
by: A-B Tonnel, et al.
Published: (2008-06-01)

Definitions of Chronic Obstructive Pulmonary Disease and Chronic Obstructive Pulmonary Disease Exacerbation: A Modified Delphi Survey
by: Yong Bum Park, et al.
Published: (2023-07-01)

Impact of Previous Occupational Exposure on Outcomes of Chronic Obstructive Pulmonary Disease
by: Youlim Kim, et al.
Published: (2022-09-01)

Comparison of pneumonia incidence between long-acting muscarinic antagonist and inhaled corticosteroid plus long-acting beta agonist in patients with COPD
by: Eung Gu Lee, et al.
Published: (2023-05-01)

Bronchodilator efficacy and safety of indacaterol 150 &micro;g once daily in patients with COPD: an analysis of pooled data
by: Bleecker ER, et al.
Published: (2011-08-01)

Clinical Manifestations of Spontaneous Pneumomediastinum
by: Soo Jin Park, et al.
Published: (2016-08-01)

Tiotropium Add-On and Treatable Traits in Asthma-COPD Overlap: A Real-World Pilot Study
by: Ishiura Y, et al.
Published: (2022-05-01)

Differential decline of lung function in COPD patients according to structural abnormality in chest CT
by: Hyun Woo Lee, et al.
Published: (2024-04-01)

Efficacy and safety of indacaterol 150 <it>μ</it>g once-daily in COPD: a double-blind, randomised, 12-week study
by: Piggott Simon, et al.
Published: (2010-03-01)

Effect of indacaterol on lung deflation improves cardiac performance in hyperinflated COPD patients: an interventional, randomized, double-blind clinical trial
by: Santus P, et al.
Published: (2015-09-01)

Clinical predictors of treatment response to tiotropium add-on therapy in adult asthmatic patients: From multicenter real-world cohort data in Korea
by: Ji-Su Shim, MD, PhD, et al.
Published: (2022-12-01)

Randomised controlled trial of a behavioural intervention to reduce exposure to PM2.5 in patients with COPD
by: Jieun Kang, et al.
Published: (2023-11-01)

COST-MINIMIZATION OF VILANTEROL / UMECLIDINIUM VERSUS OLODATEROL / TIOTROPIUM IN THE BASIC THERAPY OF SEVERE AND VERY SEVERE COPD
by: E. G. Kosolapov, et al.
Published: (2017-08-01)

Pharmacoeconomic analysis of tiotropium bromide and olodaterol fixed combination as maintenance therapy for patients with COPD in the Russian Federation
by: S. V. Nedogoda, et al.
Published: (2020-08-01)

The serotype-specific prevalence of pneumococci in hospitalized pneumonia patients with COPD: a prospective, multi-center, cohort study
by: Jae Yeol Kim, et al.
Published: (2023-09-01)

Development of a Machine Learning Model for Predicting Weaning Outcomes Based Solely on Continuous Ventilator Parameters during Spontaneous Breathing Trials
by: Ji Eun Park, et al.
Published: (2023-10-01)

The effect of ulinastatin on acute kidney injury in patients undergoing off-pump cardiac bypass surgery
by: Soo Jung Park, et al.
Published: (2024-02-01)

Roles of Inflammatory Biomarkers in Exhaled Breath Condensates in Respiratory Clinical Fields
by: Yong Jun Choi, et al.
Published: (2024-01-01)

Enhancing the interferon-γ release assay through omission of nil and mitogen values
by: Yun Jung Jung, et al.
Published: (2023-07-01)

Comparison of intraocular pressure fluctuation and glaucoma progression rate between phakic and pseudophakic eyes in pseudoexfoliation glaucoma
by: Edward Kang, et al.
Published: (2024-01-01)

The Effect of Sex on the Remimazolam Dosage Required for Successful i-gel Supraglottic Airway Insertion with Remifentanil in Non-Paralyzed Patients: An Up-and-Down Sequential Allocation Trial
by: Ju-Yeon Oh, et al.
Published: (2024-01-01)

Does the Use of Asthma-Controller Medication in Accordance with Guidelines Reduce the Incidence of Acute Exacerbations and Healthcare Costs?
by: Suh-Young Lee, et al.
Published: (2022-01-01)

COPD Exacerbation-Related Pathogens and Previous COPD Treatment
by: Yun Su Sim, et al.
Published: (2022-12-01)

Heterogeneity of asthma–chronic obstructive pulmonary disease (COPD) overlap from a cohort of patients with severe asthma and COPD
by: Joon Young Choi, et al.
Published: (2023-04-01)

Physiological Effects of Red-Colored Food-Derived Bioactive Compounds on Cardiovascular and Metabolic Diseases
by: Soo-yeon Park, et al.
Published: (2022-02-01)